National Yang Ming Chiao Tung University

Mycomagic Biotechnology Co., Ltd.

National Research Institute of Chinese Medicine, Ministry of Health and Welfare

Tung-Yi Lin

Ming-Han Tsai

Mei-Kuang Lu

Zhi-Hu Lin

Hsin Yeh

The present disclosure relates to a method for alleviating and/or treating a coronavirus disease in a subject in need thereof, including administering an effective amount ofimmunomodulatory protein, a recombinant thereof or a fragment thereof to the subject.

Immunomodulatory protein for alleviation and/or treatment of coronavirus diseases

Provided is a method for preventing or treating cancer in a subject in need thereof, including administering to the subject an effective amount of a composition including a fraction of polysaccharide isolated fromcultured in the presence of zinc sulfate and a carrier thereof, wherein the polysaccharide includes glucose and fucose. Also provided are a method for preparing the composition and a composition including the polysaccharide fraction obtained therefrom.

Composition and method for treating cancer

Provided herein is a method for preventing or treating an Epstein-Barr virus (EBV) infection, including administering to the subject in need thereof with an effective amount of immunomodulatory protein of, a recombinant thereof, or a fungal immunomodulatory protein of a similar structure. Also provided is a method for preventing or treating an EBV-associated cancer.

Growing community of inventors

Taipei, Taiwan

Tung-Yi Lin